China rare disease list could promote R&D, regulatory filings

Five Chinese government agencies, including the State Drug Administration and the National Health Commission, published a national list of 121 qualified rare diseases to support diagnosis and treatment of such conditions in a move that could spur R&D and regulatory submissions for rare disease therapies.

This is the first time

Read the full 499 word article

User Sign In